Pharmafile Logo
Pharmafocus logo
Advanced Search

MRI

Showing 6 posts of 6 posts found.

drug-trials

University of Birmingham scientists develop new MRI contrast agent

November 12, 2025
Research and Development Diagnostics, MRI, University of Birmingham, medical imaging

Researchers at the University of Birmingham, UK, have developed a new class of magnetic resonance imaging (MRI) contrast agents that …

News

Esaote presents new MRI system to support brain glioma surgeries

October 7, 2025
Research and Development Esaote, MRI, medical imaging, neurology

Gliomas are among the most common primary malignant brain tumours

News
1c64f360-c5ef-43b6-bcef-13cede36f571

Lucida Medical gains CE marking for AI prostate cancer tech

June 1, 2021
Manufacturing and Production AI, MRI, NHS, prostate cancer

Cambridge-based AI company, Lucida Medical, has received CE marking for its new machine learning-based prostate cancer detection software, Prostate Intelligence …

News

Guerbet see positive Phase III results for MRI agent

March 24, 2021
Research and Development MRI

Medical imaging company, Guerbet, have announced the success of its Phase III study into the safety and efficacy of Gadopiclenol, …

News
mri_credit_-_ptrump16

NHS trials “world-leading” initiative to cut prostate cancer diagnoses to just days

March 5, 2018
Research and Development, Sales and Marketing Cancer, MRI, NHS, pharma, prostate cancer

The NHS has revealed plans to cut the average diagnosis times for prostate cancer from six weeks to less than …

News
Bayer image

Bayer and Regeneron eye drug gains another indication

March 26, 2015
Sales and Marketing Bayer, Eylea, FDA, Japan, Lucentis, MRI, Regeneron, aflibercept

Bayer and Regeneron’s Eylea has added to a growing list of indications with its new approval to treat a type …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025